サマリー

中東・アフリカの医療用酸素ボンベ市場は、2023年の1,339,633.43千米ドルから2031年には1,941,152.08千米ドルに達すると予測され、2024～2031年の予測期間でCAGR 4.8%で成長する。
欧州の医療用酸素ボンベ市場は、2023年の4,239,438.58千米ドルから2031年には6,447,887.52千米ドルに達すると予測され、2024年から2031年の予測期間にはCAGR 5.5％で成長する。
市場区分
欧州および中東・アフリカの医療用酸素ボンベ市場、製品（携帯用酸素ボンベ、据え置き型酸素ボンベ）、技術（連続フロー、パルスフロー）、用途（慢性閉塞性肺疾患（COPD）、肺炎、肺がん、喘息、呼吸窮迫症候群、睡眠時無呼吸症候群、麻酔）、使用性（非ホームケアとホームケア）、エンドユーザー（病院、独立型救急車サービス、ホームケアの現場）、流通チャネル（第三者流通業者と直接入札）、国（ドイツ、U.K.,フランス, イタリア, スペイン, ロシア, スイス, トルコ, ベルギー, オランダ, ノルウェー, フィンランド, デンマーク, スウェーデン, ポーランド, ハンガリー, リトアニア, オーストリア, アイルランド, チェコ, ギリシャ, ポルトガル, ルーマニア, ブルガリア, ウクライナ, その他のヨーロッパ, GCC, 南アフリカ, イスラエル, エジプト, ナイジェリア, イラン, イラク, ケニア, エチオピア, その他の中東・アフリカ) - 産業動向と2031年までの予測

欧州と中東アフリカの医療用酸素ボンベ市場ダイナミクスの概要

推進要因
- 様々な治療戦略における高気圧酸素療法の適用拡大

抑制要因

- 酸素ボンベおよび濃縮器に関連する高コスト
機会

- ポータブルで軽量なボンベの技術革新により、多様な医療環境に対応可能

市場プレーヤー

中東・アフリカの医療用酸素ボンベ市場で事業を展開する主な市場参入企業は以下の通り：

- Koninklijke Philips N.V.
- 株式会社ニテラ
- リンデ
- Supera Anesthesia Innovations
- ドライブ・デビルビス・インターナショナル
- GCE
- チャート・インダストリーズ
- ユーフロー・オートメーション・インディア
- ナリーナ・ライフサイエンシズ・プライベート・リミテッド
- ハーシル
- AMSコンポジットシリンダー
- ガルフ・クライオ
- アルバラックグループ
- ベスコメディカルリミテッド
- 瀋陽カンタ医療技術有限公司LTD.
- ブルーアクアサービス
- ミーベル
- オリエントメッドインターナショナル
- 佛山キーハブ電子工業有限公司
- ロヤックス
- ウルトラコントロール
- EKC
- イノジェン
- ニデック・メディカル・プロダクツ
- Luxfer Gas Cylinders (Luxfer Holdings PLCの子会社)

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 46
1.1 OBJECTIVES OF THE STUDY 46
1.2 MARKET DEFINITION 46
1.3 OVERVIEW OF EUROPE AND MIDDLE EAST AND AFRICA MEDICAL OXYGEN CYLINDER MARKET 46
1.4 CURRENCY AND PRICING 48
1.5 LIMITATIONS 48
1.6 MARKETS COVERED 48
2 MARKET SEGMENTATION 51
2.1 MARKETS COVERED 51
2.2 YEARS CONSIDERED FOR THE STUDY 52
2.3 GEOGRAPHIC SCOPE 52
2.4 DBMR TRIPOD DATA VALIDATION MODEL 53
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 57
2.6 DBMR MARKET POSITION GRID 58
2.7 DBMR MARKET POSITION GRID 59
2.8 MARKET APPLICATION COVERAGE GRID 60
2.9 MARKET APPLICATION COVERAGE GRID 61
2.10 VENDOR SHARE ANALYSIS 62
2.11 MULTIVARIATE MODELLING 63
2.12 OFFERING TIMELINE CURVE 64
2.13 SECONDARY SOURCES 65
2.14 ASSUMPTIONS 65
3 EXECUTIVE SUMMARY 66
4 PREMIUM INSIGHTS 69
4.1 PORTER’S FIVE FORCES ANALYSIS 71
4.2 PESTEL ANALYSIS 72
4.3 INDUSTRY INSIGHTS 73
5 REGULATORY STANDARDS 75
6 MARKET OVERVIEW 78
6.1 DRIVERS 80
6.1.1 EXPANDING APPLICATION OF HYPERBARIC OXYGEN THERAPY IN VARIOUS TREATMENT STRATEGIES 80
6.1.2 GROWING DEMAND FOR OXYGEN OWING TO RISING RESPIRATORY ILLNESSES AND AGING POPULATION 81
6.1.3 EXPANDING HEALTHCARE INFRASTRUCTURE 82
6.1.4 RISING USE OF OXYGEN THERAPY IN SPORTS INJURY RECOVERY 84
6.2 RESTRAINTS 85
6.2.1 HIGH COST ASSOCIATED WITH OXYGEN CYLINDER AND CONCENTRATORS 85
6.2.2 REGULATORY COMPLIANCE RELATED TO THE APPROVAL, PRODUCTION, AND DISTRIBUTION OF MEDICAL OXYGEN EQUIPMENT 86
6.3 OPPORTUNITIES 86
6.3.1 INNOVATIONS IN PORTABLE AND LIGHTWEIGHT CYLINDERS CATER TO DIVERSE MEDICAL SETTINGS 86
6.3.2 REGIONAL COLLABORATIONS AND ALLIANCES ENHANCE ACCESSIBILITY AND DISTRIBUTION CHANNELS FOR MEDICAL OXYGEN CYLINDERS 87
6.3.3 RESEARCH ON ECO-FRIENDLY OXYGEN CYLINDER MATERIALS ADVANCES SUSTAINABILITY INITIATIVES 88
6.4 CHALLENGES 89
6.4.1 SUPPLY CHAIN ISSUES DUE TO UNSTABLE GEOPOLITICAL CONDITIONS 89
6.4.2 LIMITED ACCESS TO HEALTHCARE INFRASTRUCTURE 90
7 EUROPE AND MIDDLE EAST AND AFRICA MEDICAL OXYGEN CYLINDER MARKET, BY PRODUCT 91
7.1 OVERVIEW 92
7.2 PORTABLE OXYGEN CYLINDER 94
7.2.1 10L-50L 95
7.2.1.1 ALUMINUM CYLINDER 96
7.2.1.2 STAINLESS STEEL CYLINDER 96
7.2.2 LESS THAN 10L 96
7.2.2.1 ALUMINUM CYLINDER 97
7.2.2.2 STAINLESS STEEL CYLINDER 97
7.2.3 MORE THAN 50L 97
7.2.3.1 ALUMINUM CYLINDER 98
7.2.3.2 STAINLESS STEEL CYLINDER 98
7.3 STATIONARY OXYGEN CYLINDER 99
7.3.1 10L-50L 100
7.3.1.1 ALUMINUM CYLINDER 100
7.3.1.2 STAINLESS STEEL CYLINDER 101
7.3.2 LESS THAN 10L 101
7.3.2.1 ALUMINUM CYLINDER 101
7.3.2.2 STAINLESS STEEL CYLINDER 102
7.3.3 MORE THAN 50L 102
7.3.3.1 ALUMINUM CYLINDER 102
7.3.3.2 STAINLESS STEEL CYLINDER 103 
8 EUROPE AND MIDDLE EAST AND AFRICA MEDICAL OXYGEN CYLINDER MARKET, BY TECHNOLOGY 104
8.1 OVERVIEW 105
8.2 CONTINUOUS FLOW 107
8.3 PULSE FLOW 107
9 EUROPE AND MIDDLE EAST AND AFRICA MEDICAL OXYGEN CYLINDER MARKET, BY APPLICATION 108
9.1 OVERVIEW 109
9.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 112
9.3 PNEUMONIA 112
9.4 LUNG CANCER 112
9.5 ASTHMA 112
9.6 RESPIRATORY DISTRESS SYNDROME 112
9.7 SLEEP APNEA 113
9.8 ANESTHESIA 113
9.9 OTHERS 113
10 EUROPE AND MIDDLE EAST AND AFRICA MEDICAL OXYGEN CYLINDER MARKET, BY USABILITY 114
10.1 OVERVIEW 115
10.2 NON-HOME CARE 117
10.3 HOME-CARE 117
11 EUROPE AND MIDDLE EAST AND AFRICA MEDICAL OXYGEN CYLINDER MARKET, BY END-USER 118
11.1 OVERVIEW 119
11.2 HOSPITALS 122
11.2.1 INTENSIVE CARE UNITS (ICU) 122
11.2.2 EMERGENCY CARE DEPARTMENTS 123
11.2.3 OPERATING ROOMS 123
11.2.4 OTHERS 123
11.3 STANDALONE AMBULANCE SERVICES 123
11.4 HOME-CARE SETTINGS 123
11.5 OTHERS 124 
12 EUROPE AND MIDDLE EAST AND AFRICA MEDICAL OXYGEN CYLINDER MARKET, BY DISTRIBUTION CHANNEL 125
12.1 OVERVIEW 126
12.2 THIRD PARTY DISTRIBUTORS 129
12.3 DIRECT TENDER 129
12.4 OTHERS 129
13 EUROPE AND MIDDLE EAST AND AFRICA MEDICAL OXYGEN CYLINDER MARKET, BY REGION 130
13.1 EUROPE 130
13.1.1 GERMANY 133
13.1.2 U.K. 138
13.1.3 FRANCE 143
13.1.4 ITALY 148
13.1.5 SPAIN 153
13.1.6 RUSSIA 158
13.1.7 SWITZERLAND 163
13.1.8 TURKEY 168
13.1.9 BELGIUM 173
13.1.10 NETHERLANDS 178
13.1.11 NORWAY 183
13.1.12 FINLAND 188
13.1.13 DENMARK 193
13.1.14 SWEDEN 198
13.1.15 POLAND 203
13.1.16 HUNGARY 208
13.1.17 LITHUANIA 213
13.1.18 AUSTRIA 218
13.1.19 IRELAND 223
13.1.20 CZECHIA 228
13.1.21 GREECE 233
13.1.22 PORTUGAL 238
13.1.23 ROMANIA 243
13.1.24 BULGARIA 248
13.1.25 UKRAINE 253
13.1.26 REST OF EUROPE 258 
13.2 MIDDLE EAST AND AFRICA 259
13.2.1 GCC 262
13.2.2 SOUTH AFRICA 267
13.2.3 ISRAEL 272
13.2.4 EGYPT 277
13.2.5 NIGERIA 282
13.2.6 IRAN 287
13.2.7 IRAQ 292
13.2.8 KENYA 297
13.2.9 ETHIOPIA 302
13.2.10 REST OF MIDDLE EAST AND AFRICA 307
14 EUROPE AND MIDDLE EAST AND AFRICA MEDICAL OXYGEN CYLINDER MARKET: COMPANY LANDSCAPE 308
14.1 COMPANY SHARE ANALYSIS: EUROPE 308
14.2 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 309
15 SWOT ANALYSIS 310
16 COMPANY PROFILE 311
16.1 AL-BARRAK GROUP 311
16.1.1 COMPANY SNAPSHOT 311
16.1.2 PRODUCT PORTFOLIO 311
16.1.3 RECENT DEVELOPMENTS 311
16.2 AMS COMPOSITE CYLINDERS 312
16.2.1 COMPANY SNAPSHOT 312
16.2.2 PRODUCT PORTFOLIO 312
16.2.3 RECENT DEVELOPMENTS 312
16.3 BESCO MEDICAL LIMITED 313
16.3.1 COMPANY SNAPSHOT 313
16.3.2 PRODUCT PORTFOLIO 313
16.3.3 RECENT DEVELOPMENTS 314
16.4 BLUAQUA SERVICE GMBH & CO. 315
16.4.1 COMPANY SNAPSHOT 315
16.4.2 PRODUCT PORTFOLIO 315
16.4.3 RECENT DEVELOPMENTS 315
16.5 CHART INDUSTRIES 316
16.5.1 COMPANY SNAPSHOT 316
16.5.2 REVENUE ANALYSIS 316
16.5.3 PRODUCT PORTFOLIO 317
16.5.4 RECENT DEVELOPMENT 317
16.6 DRIVE DEVILBISS INTERNATIONAL 318
16.6.1 COMPANY SNAPSHOT 318
16.6.2 PRODUCT PORTFOLIO 318
16.6.3 RECENT DEVELOPMENTS 319
16.7 EKC 320
16.7.1 COMPANY SNAPSHOT 320
16.7.2 REVENUE ANALYSIS 320
16.7.3 PRODUCT PORTFOLIO 321
16.7.4 RECENT DEVELOPMENT 321
16.8 FOSHAN KEYHUB ELECTRONIC INDUSTRIES CO.,LTD 322
16.8.1 COMPANY SNAPSHOT 322
16.8.2 PRODUCT PORTFOLIO 322
16.8.3 RECENT DEVELOPMENT 323
16.9 GCE 324
16.9.1 COMPANY SNAPSHOT 324
16.9.2 PRODUCT PORTFOLIO 324
16.9.3 RECENT DEVELOPMENT 326
16.10 GULF CRYO 327
16.10.1 COMPANY SNAPSHOT 327
16.10.2 PRODUCT PORTFOLIO 327
16.10.3 RECENT DEVELOPMENTS 327
16.11 HERSILL 329
16.11.1 COMPANY SNAPSHOT 329
16.11.2 PRODUCT PORTFOLIO 329
16.11.3 RECENT DEVELOPMENTS 329
16.12 INOGEN, INC. 331
16.12.1 COMPANY SNAPSHOT 331
16.12.2 REVENUE ANALYSIS 331
16.12.3 PRODUCT PORTFOLIO 332
16.12.4 RECENT DEVELOPMENTS 333
16.13 KONINKLIJKE PHILIPS N.V. 334
16.13.1 COMPANY SNAPSHOT 334
16.13.2 REVENUE ANALYSIS 334
16.13.3 PRODUCT PORTFOLIO 335
16.13.4 RECENT DEVELOPMENTS 335
16.14 LINDE PLC 336
16.14.1 COMPANY SNAPSHOT 336
16.14.2 REVENUE ANALYSIS 336
16.14.3 PRODUCT PORTFOLIO 337
16.14.4 RECENT DEVELOPMENT 337
16.15 LUXFER GAS CYLINDERS (SUBSIDIARY OF LUXFER HOLDINGS PLC) 338
16.15.1 COMPANY SNAPSHOT 338
16.15.2 REVENUE ANALYSIS 338
16.15.3 PRODUCT PORTFOLIO 339
16.15.4 RECENT DEVELOPMENT 339
16.16 ME.BER. SRL. 341
16.16.1 COMPANY SNAPSHOT 341
16.16.2 PRODUCT PORTFOLIO 341
16.16.3 RECENT DEVELOPMENTS 342
16.17 NAREENA LIFESCIENCES PRIVATE LIMITED 343
16.17.1 COMPANY SNAPSHOT 343
16.17.2 PRODUCT PORTFOLIO 343
16.17.3 RECENT DEVELOPMENT 344
16.18 NIDEK MEDICAL PRODUCT, INC. 345
16.18.1 COMPANY SNAPSHOT 345
16.18.2 PRODUCT PORTFOLIO 345
16.18.3 RECENT DEVELOPMENT 347
16.19 NITERRA CO., LTD. 348
16.19.1 COMPANY SNAPSHOT 348
16.19.2 REVENUE ANALYSIS 348
16.19.3 PRODUCT PORTFOLIO 349
16.19.4 RECENT DEVELOPMENTS 349
16.20 ORIENTMED INTERNATIONAL 350
16.20.1 COMPANY SNAPSHOT 350
16.20.2 PRODUCT PORTFOLIO 350
16.20.3 RECENT DEVELOPMENTS 350
16.21 ROYAX 351
16.21.1 COMPANY SNAPSHOT 351
16.21.2 PRODUCT PORTFOLIO 351
16.21.3 RECENT DEVELOPMENT 352
16.22 SHENYANG CANTA MEDICAL TECH. CO., LTD. 353
16.22.1 COMPANY SNAPSHOT 353
16.22.2 PRODUCT PORTFOLIO 353
16.22.3 RECENT DEVELOPMENTS 355
16.23 SUPERA ANESTHESIA INNOVATIONS 356
16.23.1 COMPANY SNAPSHOT 356
16.23.2 SOLUTION PORTFOLIO 356
16.23.3 RECENT DEVELOPMENTS 358 
16.24 UFLOW AUTOMATION INDIA 359
16.24.1 COMPANY SNAPSHOT 359
16.24.2 PRODUCT PORTFOLIO 359
16.24.3 RECENT DEVELOPMENTS 359
16.25 ULTRA CONTROLO 360
16.25.1 COMPANY SNAPSHOT 360
16.25.2 PRODUCT PORTFOLIO 360
16.25.3 RECENT DEVELOPMENTS 361
17 QUESTIONNAIRE 362
18 RELATED REPORTS 366